Glaxo Rumored to Eliminate 350 Jobs in Philadelphia and Research Triangle Park

The pharma downsizing bandwagon continues to roll. Today, there are unconfirmed reports that GlaxoSmithKline will eliminate about 350 jobs at its R&D facilities in Philadelphia, PA and Research Triangle Park, NC.  The area that will be hardiest hit by the cuts is Glaxo’s oncology program, which has not yield much over the past decade or so.

Expect the pharma downsizing trend to continue well into this Fall.

Until next time….

Good Luck and Good Job Hunting (if there are any left to find)!!!!!!

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.biojobblog.com/admin/trackback/82432
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.